Investor Attention and Crowdfunding Performance
Academy of Management Proceedings · 2023-08 · 2023 (1)
DOI: 10.5465/amproc.2023.16704abstract ↗Kurz gefasst
Fachartikel in der Zeitschrift Academy of Management Proceedings, 2023-08. Verfasst von Lin Hu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
We propose a novel mechanism---backers' limited attention---through which early-stage performance of a crowdfunding project can potentially affect following backers' herding behavior and so the final outcome. To this end, we develop a model to analyze how backers with limited attention optimally acquire information and make investment decisions. By aggregating individual backers' information acquisition and investment decisions, we study how shocks to backers' attention cost affect overall attention received by and performance of the project. By allowing following backers to herd onto the aggregate decision of leading backers, we investigate how shocks to the leading backers' attention can affect the final outcome. Based on model predictions, we empirically test (i) the effect of distractions to backers' attention on their information acquisition and investment decisions; and (ii) the presence of backers' herding behavior, that is, whether following backers' investment decisions are influenced by early-stage performance of the campaign.
Zitieren
APA
Hu, L., Li, K., Wu, Z., & Gu, B. (2023). Investor Attention and Crowdfunding Performance. Academy of Management Proceedings, 2023(1). https://doi.org/10.5465/amproc.2023.16704abstract
Vancouver
Hu L, Li K, Wu Z, Gu B. Investor Attention and Crowdfunding Performance. Academy of Management Proceedings. 2023;2023(1). doi:10.5465/amproc.2023.16704abstract
BibTeX
@article{Hu2023,
author = {Hu, Lin and Li, Kun and Wu, Zhenhua and Gu, Bin},
title = {Investor Attention and Crowdfunding Performance},
journal = {Academy of Management Proceedings},
year = {2023},
volume = {2023},
number = {1},
doi = {10.5465/amproc.2023.16704abstract}
}
EUVIMED